Debut Plus

₹16.82

▼ -0.14 -0.83%

17 Jul 2026

BSE Listed

GSM 0

Bharat Immunologicals & B (524663)

Volume: 16,284Avg Vol 1W: 17,917Avg Vol 1M: 22,39852W Range:₹14.1₹23.49
BSE www.bibcol.com
Key Ratios
Checked just now
Market Cap₹73 Cr
Current Price₹16.82
Previous Close₹16.96
High / Low (52w)₹23.49 / ₹14.1
Volume16,284
Avg Vol (1W)17,917
Avg Vol (1M)22,398
Stock P/E—
Book Value₹-7.54
Dividend Yield0%
ROE-22.95%
ROA-9.61%
Revenue (TTM)—
Revenue Growth—
Profit Margin-236.21%
Total Debt—
Shares Outstanding4 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹17.33
200 DMA₹18.56
Day change-0.83%
SurveillanceGSM 0 (as of 2026-07-17)
Price Chart
₹16.82▼ 26.65% · 1Y
₹25₹142.8L
2025-07-16
2026-07-16

20-day avg volume: 23K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 40% YoY.
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricDec 2021Mar 2022Jun 2022Sept 2022Dec 2022Mar 2023Jun 2023Sept 2023
Revenue₹17 Cr₹22 Cr₹10 Cr₹26 Cr₹0 Cr₹8 Cr₹0 Cr₹0 Cr
EBITDA₹1 Cr₹-3 Cr₹-5 Cr₹-2 Cr₹-5 Cr₹-4 Cr₹-4 Cr₹-5 Cr
Net Profit₹0 Cr₹-4 Cr₹-5 Cr₹-3 Cr₹-5 Cr₹-4 Cr₹-5 Cr₹-5 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Revenue₹129 Cr₹125 Cr₹36 Cr₹88 Cr₹68 Cr₹87 Cr₹79 Cr₹47 Cr
EBITDA₹-4 Cr₹13 Cr₹-7 Cr₹-5 Cr₹-9 Cr₹-19 Cr₹-4 Cr₹-16 Cr
Net Profit₹-6 Cr₹7 Cr₹-4 Cr₹-6 Cr₹-10 Cr₹-18 Cr₹-9 Cr₹-17 Cr
EPS-1.441.51-0.99-1.34-2.361.1-2.03-3.95
Balance Sheet
MetricMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Total Assets₹68 Cr₹59 Cr₹53 Cr₹125 Cr₹127 Cr₹104 Cr₹213 Cr₹186 Cr
Total Liabilities₹33 Cr₹17 Cr₹16 Cr₹94 Cr₹106 Cr₹70 Cr₹107 Cr₹98 Cr
Equity₹35 Cr₹42 Cr₹37 Cr₹31 Cr₹20 Cr₹34 Cr₹105 Cr₹88 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023
Operating₹12 Cr₹-42 Cr₹11 Cr
Investing₹1 Cr₹1 Cr₹0 Cr
Financing₹-12 Cr₹45 Cr₹-15 Cr
Free Cash Flow₹12 Cr₹-42 Cr₹11 Cr
Shareholding
Promoter 59.25% Institutions 0% Public 40.75%
Efficiency & Working Capital
ROCE-11.2%
Interest Coverage-2.2
Dividend Payout—
Debtor Days114 d
Inventory Days12 d
Payable Days4 d
Cash Conversion Cycle121 d
Working Capital Days125 d
Shareholding Details

As of 2024-03-31

Promoter59.3%
FII0%
DII0%
Institutions0%
Public40.7%
Promoter Pledge0%
No. of Shareholders35,313
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2021Sept 2021Dec 2021Mar 2022Jun 2022Sept 2022Dec 2022Mar 2023Jun 2023Sept 2023Dec 2023Mar 2024
Promoters59.3%59.3%59.3%59.3%59.3%59.3%59.3%59.3%59.3%59.3%59.3%59.3%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public40.7%40.7%40.7%40.7%40.7%40.7%40.7%40.7%40.7%40.7%40.7%40.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders38,19536,79936,86936,32335,69535,41136,24235,53534,81834,20134,91035,313
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202303————
Major Shareholders (>1%)
NameCategoryStakeShares
President Of IndiaShareholding of Promoter and Promoter Group59.3%2.56 Cr
Dr Rajesh S Gokhale, Secretary DbtShareholding of Promoter and Promoter Group0%1
Sh Vishwajit Sahay As&fa, DbtShareholding of Promoter and Promoter Group0%1
Dr Sanjay Mishra, Scientist H, DbtShareholding of Promoter and Promoter Group0%1
Dr Alka Sharma, Scientist H, DbtShareholding of Promoter and Promoter Group0%1
Dr Dhananjay Tiwary, Scientist G, DbtShareholding of Promoter and Promoter Group0%1
Dr Nitin K Jain, Scientist G, DbtShareholding of Promoter and Promoter Group0%1
Sh Pankaj Upadhyay, Ds, DbtShareholding of Promoter and Promoter Group0%1
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Dr Rajesh S Gokhale, Secretary Dbt00%2024-03-31
Sh Vishwajit Sahay As&fa, Dbt00%2024-03-31
Dr Sanjay Mishra, Scientist H, Dbt00%2024-03-31
Dr Alka Sharma, Scientist H, Dbt00%2024-03-31
Dr Dhananjay Tiwary, Scientist G, Dbt00%2024-03-31
Dr Nitin K Jain, Scientist G, Dbt00%2024-03-31
Sh Pankaj Upadhyay, Ds, Dbt00%2024-03-31
President Of India00%2024-03-31
Dr Rajesh S Gokhale, Secretary Dbt00%2023-12-31
Sh Vishwajit Sahay, As&fa, Dbt00%2023-12-31
Dr Sanjay Mishra, Scientist H, Dbt00%2023-12-31
Dr Alka Sharma, Scientist H, Dbt00%2023-12-31
Board of Directors
NameDesignationYear
Y K GuptaChairman & Independent Director2022
Sandip K LalCompany Sec. & Compli. Officer2022
Alka SharmaIndependent Director2022
Mohd AslamIndependent Director2022
Sudhanshu VratiIndependent Director2022
Madhu DikshitIndependent Director2022
Sanjay Kumar MishraManaging Director2022
Pankaj KumarIndependent Director2022
Segments — Product
SegmentRevenueShare
Oral Polio Vaccine₹45 Cr100%
Zinc Tablets₹0 Cr0%
BIBSANIT₹0 Cr0%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2023₹10514343
Company Information
Incorporated1989
ChairmanY K Gupta
AuditorReshma & Co
Investor Email[email protected]
🌐 www.bibcol.com ↗

📍 BIBCOL OPV Plant Village Chola, Bulandshahr, Uttar Pradesh, 203203

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Oxygenta Pharmaceutical LimitedArchit Organosys Ltd.Sikozy Realtors LimitedIndo AminesNatural CapsulesWelcure Drugs & PharmaceuSavita Oil TechnologiesKabsons Industries Ltd.Basant Agro Tech (India)Sandu Pharmaceuticals Ltd.Vista Pharmaceuticals Ltd.Sun PharmaceuticalAll “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search